Cause of Death in Patients with Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)

Charytan, David M.Lewis, E. F.Desai, Akshay S.Weinrauch, Larry A.Ivanovich, PeterToto, Robert D.Claggett, Brian L.Liu, JiankangHartley, L. HowardFinn, PeterSingh, Ajay K.Levey, Andrew S.Pfeffer, Marc A.McMurray, JohnSolomon, Scott2025-10-1720150272-638610.1053/j.ajkd.2015.02.324https://hdl.handle.net/20.500.14802/34140Cause of Death in Patients with Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)Journal article2-s2.0-84936857235Controlled201045889